Your Future is in your Freedom

Narcotics Pardons

All narcotics possession charges stay on your record. Whether it’s pot or other narcotics, the list is very long. Trafficking (selling and distribution) and production of a drug/narcotic are more serious offences and result in much harsher penalties.

If you’re looking for a cannabis pardon, also known as a pot pardon, read this.

A pardon is now called a record suspension and drug-related offences have their own specific legislation called the Controlled Drugs and Substances Act. Interestingly, there are schedules for the types of drugs. (The long list is located at the bottom of this article.)

The schedule type not only affects sentencing but the pardon process as well. For example: the waiting period can differ if it’s a possession versus a trafficking charge as you are looking at a five year waiting period versus a ten year waiting period.

The US will not allow you to cross the border if you have any drug-related charges. You can apply for a US Entry Waiver.  Pardons and US Entry Waivers are different documents and do different things.

As you can see below, it is very complicated, making the application for a pardon very specific. We have a lot of experience with narcotics pardons, so contact us for a free consultation for your specific case.

Penalties

Possession

If tried as an indictable offence, the defendant is liable to:

  • Schedule I: Maximum 7 years’ imprisonment
  • Schedule II: Maximum 5 years’ imprisonment
  • Schedule III: Maximum 3 years’ imprisonment
  • Schedule IV: It is not an indictable offence to possess a Schedule IV substance for personal use.
  • If tried as a summary conviction offence, the defendant is liable to:
  • Schedule I, II, or III: Maximum $1000 fine for the first offence and/or a maximum 6-month term of imprisonment, increasing to a maximum fine of $2000 for each subsequent offense and/or a maximum of 1 year in prison.
  • Schedule IV: It is not a summary offence to possess a Schedule IV substance for personal use.

It should also be noted that Section (4), Subsection (2) of the CDSA reads that any person who obtains or who makes any attempt to obtain a Schedule I through IV substance from a physician without fully disclosing the details of any previous instances of obtaining a Schedule I through IV substance in the preceding thirty (30) days, a practice often referred to as “doctor shopping”,[3] is guilty of a summary or indictable offence, as per Section (4), Subsection (7)(a) and (b).[4]

Trafficking/Possession for the Purpose of

If tried as an indictable offence, the defendant is liable to:

  • Schedule I or Schedule II: Maximum life imprisonment
  • Schedule III: Maximum 10 years’ imprisonment
  • Schedule IV: Maximum 3 years’ imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

  • Schedule III: Maximum 18 months’ imprisonment
  • Schedule IV: Maximum 1 year’s imprisonment

Exportation/Possession for the Purpose of

If tried as an indictable offence, the defendant is liable to:

  • Schedule I or Schedule II: Maximum life imprisonment
  • Mandatory minimum 1 year imprisonment for exporting a Schedule I drug under 1 kg, 2 years if amount exceeds 1 kg
  • Schedule III or Schedule IV: Maximum 10 years’ imprisonment
  • Schedule V or Schedule VI: Maximum 3 years’ imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

  • Schedule III or Schedule IV: Maximum 18 months’ imprisonment
  • Schedule V or Schedule VI: Maximum 1 year’s imprisonment

Production

If tried as an indictable offence, the defendant is liable to:

  • Schedule I or Schedule II: Maximum life imprisonment
  • Mandatory minimum 2 year imprisonment
  • Schedule III: Maximum 10 years’ imprisonment
  • Schedule IV: Maximum 3 years’ imprisonment

Or, if tried as a summary conviction, the defendant is liable to:

  • Schedule III: Maximum 18 months’ imprisonment
  • Schedule IV: Maximum 1 year’s imprisonment

List from Wikipedia

Schedule I

  • Opium Poppy (Papaver somniferum), its preparations, derivatives, alkaloids and salts, including:
  • Opium
  • Codeine (methylmorphine)
  • Morphine (7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol)
  • Thebaine (paramorphine)
  • and the salts, derivatives and salts of derivatives of the substances set out in subitems (1) to (4), including:
  • Acetorphine (acetyletorphine)
  • Acetyldihydrocodeine (4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol acetate)
  • Benzylmorphine (7,8-didehydro-4,5-epoxy-17-methyl-3-(phenylmethoxy) morphinan-6-ol)
  • Codoxime (dihydrocodeinone O-(carboxymethyl) oxime)
  • Desomorphine (dihydrodeoxymorphine)
  • Diacetylmorphine (heroin)
  • Dihydrocodeine (4,5-epoxy-3-methoxy-17-methylmorphinan-6-ol)
  • Dihydromorphine (4,5-epoxy-17-methylmorphinan-3,6-diol)
  • Ethylmorphine (7,8-didehydro-4,5-epoxy-3-ethoxy-17-methylmorphinan-6-ol)
  • Etorphine (tetrahydro-7α-(1-hydroxy-1-methyl-butyl)-6,14-endo-ethenooripavine)
  • Hydrocodone (dihydrocodeinone)
  • Hydromorphinol (dihydro-14-hydroxymorphine)
  • Hydromorphone (dihydromorphinone)
  • Methyldesorphine (Δ6-deoxy-6-methylmorphine)
  • Methyldihydromorphine (dihydro-6-methylmorphine)
  • Metopon (dihydromethylmorphinone)
  • Morphine-N-oxide (morphine oxide)
  • Myrophine (benzylmorphine myristate)
  • Nalorphine (N-allylnormorphine)
  • Nicocodine (6-nicotinylcodeine)
  • Nicomorphine (dinicotinylmorphine)
  • Norcodeine (N-desmethylcodeine)
  • Normorphine (N-desmethylmorphine)
  • Oxycodone (dihydrohydroxycodeinone)
  • Oxymorphone (dihydrohydroxymorphinone)
  • Pholcodine (3-[2-(4-morpholinyl)ethyl]morphine)
  • Thebacon (acetyldihydrocodeinone)
  • but not including:
  • Apomorphine (5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol) and its salts
  • Cyprenorphine (N-(cyclopropylmethyl)-6,7,8,14-tetrahydro-7α-(1-hydroxy-1-methylethyl)-6,14-endo-ethenonororipavine) and its salts
  • Nalmefene (17-(cyclopropylmethyl)-4,5α-epoxy-6-methylenemorphinan-3,14-diol) and its salts
  • Naloxone (4,5α-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one) and its salts
  • Naltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxymorphinan-6-one) and its salts
  • Methylnaltrexone (17-(cyclopropylmethyl)-4,5α-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium) and its salts
  • Naloxegol (4,5α-epoxy-6α-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propenyl)morphinan-3,14-diol) and its salts
  • Narcotine (6,7-dimethoxy-3-(5,6,7,8-tetra-hydro-4-methoxy-6-methyl-1,3-dioxolos [4,5-g]isoquinolin-5-yl)-1(3H)-isobenzofuranone) and its salts
  • Papaverine (1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline) and its salts
  • Poppy seed
  • Coca (Erythroxylon), its preparations, derivatives, alkaloids and salts, including:
  • Coca leaves
  • Cocaine (benzoylmethylecgonine)
  • Ecgonine (3-hydroxy-2-tropane carboxylic acid)
  • Phenylpiperidines, their intermediates, salts, derivatives and analogues and salts of intermediates, derivatives and analogues, including:
  • Allylprodine (3-allyl-1-methyl-4-phenyl-4-piperidinol propionate)
  • Alphameprodine (α-3-ethyl-1-methyl-4-phenyl-4-piperidinol propionate)
  • Alphaprodine (α-1,3-dimethyl-4-phenyl-4-piperidinol propionate)
  • Anileridine (ethyl 1-[2-(p-aminophenyl)ethyl]-4-phenylpiperidine-4-carboxylate)
  • Betameprodine (β-3-ethyl-1-methyl-4-phenyl-4-piperidinol propionate)
  • Betaprodine (β-1,3-dimethyl-4-phenyl-4-piperidinol propionate)
  • Benzethidine (ethyl 1-(2-benzyloxyethyl)-4-phenylpiperidine-4-carboxylate)
  • Diphenoxylate (ethyl 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
  • Difenoxin (1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylate)
  • Etoxeridine (ethyl 1-[2-(2-hydroxyethoxy) ethyl]-4-phenylpiperidine-4-carboxylate)
  • Furethidine (ethyl 1-(2-tetrahydrofurfury loxyethyl)-4-phenylpiperidine-4-carboxylate)
  • Hydroxypethidine (ethyl 4-(m-hydroxyphenyl)-1-methylpiperidine-4-carboxylate)
  • Ketobemidone (1-[4-(m-hydroxyphenyl)-1-methyl-4-piperidyl]-1-propanone)
  • Methylphenylisonipecotonitrile (4-cyano-1-methyl-4-phenylpiperidine)
  • Morpheridine (ethyl 1-(2-morpholinoethyl)-4-phenylpiperidine-4-carboxylate)
  • Norpethidine (ethyl 4-phenylpiperidine-4-carboxylate)
  • Pethidine (ethyl 1-methyl-4-phenylpiperidine-4-carboxylate)
  • Phenoperidine (ethyl 1-(3-hydroxy-3-phenylpropyl)-4-phenylpiperidine-4-carboxylate)
  • Piminodine (ethyl 1-[3-(phenylamino)propyl]-4-phenylpiperidine-4-carboxylate)
  • Properidine (isopropyl 1-methyl-4-phenylpiperidine-4-carboxylate)
  • Trimeperidine (1,2,5-trimethyl-4-phenyl-4-piperidinol propionate)
  • Pethidine Intermediate C (1-methyl-4-phenylpiperidine-4-carboxylate)
  • but not including:
  • Carbamethidine (ethyl 1-(2-carbamylethyl)-4-phenylpiperidine-4-carboxylate) and its salts
  • Oxpheneridine (ethyl 1-(2-hydroxy-2-phenylethyl)-4-phenylpiperidine-4-carboxylate) and its salts
  • Phenazepines, their salts, derivatives and salts of derivatives including:
  • Proheptazine (hexahydro-1,3-dimethyl-4-phenyl-1H-azepin-4-ol propionate)
  • but not including:
  • Ethoheptazine (ethyl hexahydro-1-methyl-4-phenyl-azepine-4-carboxylate) and its salts
  • Metethoheptazine (ethyl hexahydro-1,3-dimethyl-4-phenylazepine-4-carboxylate) and its salts
  • Metheptazine (ethyl hexahydro-1,2-dimethyl-4-phenylazepine-4-carboxylate) and its salts
  • Amidones, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
  • Dimethylaminodiphenylbutanonitrile (4-cyano-2-dimethylamino-4,4-diphenylbutane)
  • Dipipanone (4,4-diphenyl-6-piperidino-3-heptanone)
  • Isomethadone (6-dimethylamino-5-methyl-4,4-diphenyl-3-hexanone)
  • Methadone (6-dimethylamino-4,4-diphenyl-3-heptanone)
  • Normethadone (6-dimethylamino-4,4-diphenyl-3-hexanone)
  • Norpipanone (4,4-diphenyl-6-piperidino-3-hexanone)
  • Phenadoxone (6-morpholino-4,4-diphenyl-3-heptanone)
  • Methadols, their salts, derivatives and salts of derivatives including:
  • Acetylmethadol (6-dimethylamino-4,4-diphenyl-3-heptanol acetate)
  • Alphacetylmethadol (α-6-dimethylamino-4,4-diphenyl-3-heptanol acetate)
  • Alphamethadol (α-6-dimethylamino-4,4-diphenyl-3-heptanol)
  • Betacetylmethadol (β-6-dimethylamino-4,4-diphenyl-3-heptanol acetate)
  • Betamethadol (β-6-dimethylamino-4,4-diphenyl-3-heptanol)
  • Dimepheptanol (6-dimethylamino-4,4-diphenyl-3-heptanol)
  • Noracymethadol (α-6-methylamino-4,4-diphenyl-3-heptanol acetate)
  • Phenalkoxams, their salts, derivatives and salts of derivatives including:
  • Dimenoxadol (dimethylaminoethyl 1-ethoxy-1,1-diphenylacetate)
  • Dioxaphetyl butyrate (ethyl 2,2-diphenyl-4-morpholinobutyrate)
  • Dextropropoxyphene ([S-(R*,S*)]-α-[2-(dimethylamino)-1-methylethyl]-α-phenylbenzeneethanol, propanoate ester)
  • Thiambutenes, their salts, derivatives and salts of derivatives including:
  • Diethylthiambutene (N,N-diethyl-1-methyl-3,3-di-2-thienylallylamine)
  • Dimethylthiambutene (N,N,1-trimethyl-3,3-di-2-thienylallylamine)
  • Ethylmethylthiambutene (N-ethyl-N,1-dimethyl-3,3-di-2-thienylallylamine)
  • Moramides, their intermediates, salts, derivatives and salts of intermediates and derivatives including:
  • Dextromoramide (d-1-(3-methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
  • Diphenylmorpholinoisovaleric acid (2-methyl-3-morpholino-1,1-diphenylpropionic acid)
  • Levomoramide (l-1-(3-methyl-4-morpholino-2,2-diphenylbutyryl)pyrrolidine)
  • Racemoramide (d,l-1-(3-methyl-4-morpholino-2,2-diphenylbutyryl) pyrrolidine)
  • Morphinans, their salts, derivatives and salts of derivatives including:
  • Buprenorphine (17-(cyclopropylmethyl)-α-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-α-methyl-6,14-ethenomorphinan-7-methanol)
  • Drotebanol (6β,14-dihydroxy-3,4-dimethoxy-17-methylmorphinan)
  • Levomethorphan (l-3-methoxy-17-methylmorphinan)
  • Levorphanol (l-3-hydroxy-17-methylmorphinan)
  • Levophenacylmorphan (l-3-hydroxy-17-phenacylmorphinan)
  • Norlevorphanol (l-3-hydroxymorphinan)
  • Phenomorphan (3-hydroxy-17-(2-phenylethyl)morphinan)
  • Racemethorphan (d,1-3-methoxy-17-methylmorphinan)
  • Racemorphan (d,l-3-hydroxy-N-methylmorphinan)

but not including:

  • Dextromethorphan (d-1,2,3,9,10,10a-hexahydro-6-methoxy-11-methyl-4H-10,4a-iminoethano-phenanthren) and its salts
  • Dextrorphan (d-1,2,3,9,10,10a-hexahydro-11-methyl-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
  • Levallorphan (l-11-allyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
  • Levargorphan (l-11-propargyl-1,2,3,9,10,10a-hexahydro-4H-10,4a-iminoethanophenanthren-6-ol) and its salts
  • Butorphanol (17-(cyclobutylmethyl)morphinan-3,14-diol) and its salts
  • Nalbuphine (17-(cyclobutylmethyl)-4,5α-epoxymorphinan-3,6α, 14-triol) and its salts
  • Benzazocines, their salts, derivatives and salts of derivatives including:
  • Phenazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-phenethyl-2,6-methano-3-benzazocin-8-ol)
  • Metazocine (1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-2,6-methano-3-benzazocin-8-ol)
  • Pentazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol)

but not including:

  • Cyclazocine (1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(cyclopropylmethyl)-2,6-methano-3-benzazocin-8-ol) and its salts
  • Ampromides, their salts, derivatives and salts of derivatives including:
  • Diampromide (N-[2-(methylphenethylamino)propyl] propionanilide)
  • Phenampromide (N-(1-methyl-2-piperidino) ethyl) propionanilide)
  • Propiram (N-(1-methyl-2-piperidinoethyl)-N-2-pyridylpropionamide)
  • Benzimidazoles, their salts, derivatives and salts of derivatives including:
  • Clonitazene (2-(p-chlorobenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
  • Etonitazene (2-(p-ethoxybenzyl)-1-diethylaminoethyl-5-nitrobenzimidazole)
  • Bezitramide (1-(3-cyano-3,3-diphenylpropyl)-4-(2-oxo-3-propionyl-1-benzimidazolinyl)-piperidine)
  • Phencyclidine (1-(1-phenylcyclohexyl)piperidine), its salts, derivatives and analogues and salts of derivatives and analogues, including:
  • Ketamine (2-(2-chlorophenyl)-2-(methylamino)cyclohexanone)
  • Piritramide (1-(3-cyano-3,3-diphenylpropyl)-4-(1-piperidino)piperidine-4-carboxylic acid amide), its salts, derivatives and salts of derivatives
  • Fentanyls, their salts, derivatives, and analogues and salts of derivatives and analogues, including:
  • Acetyl-α-methylfentanyl (N-[1-(α-methylphenethyl)-4-piperidyl] acetanilide)
  • Alfentanil (N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide)
  • Carfentanil (methyl 4-[(1-oxopropyl)phenylamino]-1-(2-phenethyl)-4-piperidinecarboxylate)
  • p-Fluorofentanyl (4′fluoro-N-(1-phenethyl-4-piperidyl) propionanilide)
  • Fentanyl (N-(1-phenethyl-4-piperidyl) propionanilide)
  • β-Hydroxyfentanyl (N-[1-(β-hydroxyphenethyl)-4-piperidyl] propionanilide)
  • β-Hydroxy-3-methylfentanyl (N-[1-(β-hydroxyphenethyl)-3-methyl-4-piperidyl] propionanilide)
  • α-Methylfentanyl (N-[1-(α-methylphenethyl)-4-piperidyl] propionanilide)
  • α-Methylthiofentanyl (N-[1-[1-methyl-2-(2-thienyl) ethyl]-4-piperidyl] propionanilide)
  • 3-Methylfentanyl (N-(3-methyl-1-phenethyl-4-piperidyl) propionanilide)
  • 3-Methylthiofentanyl (N-[3-methyl-1-[2-(2-thienyl) ethyl]-4-piperidyl] propionanilide)
  • Remifentanil (dimethyl 4-carboxy-4-(N-phenylpropionamido)-1-piperidinepropionate)
  • Sufentanil (N-[4-(methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide)
  • Thiofentanyl (N-[1-[2-(2-thienyl)ethyl]-4-piperidyl] propionanilide)
  • Tilidine (ethyl2-(dimethylamino)-1-phenyl-3-cyclohexene-1-carboxylate), its salts, derivatives and salts of derivatives
  • Methylenedioxypyrovalerone (MDPV), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
  • Methamphetamine (N,α-dimethylbenzeneethanamine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues
  • Amphetamines, their salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues including:
  • Amphetamine (α-methylbenzene-ethanamine)
  • N-ethylamphetamine (N-ethyl-α-methylbenzeneethanamine)
  • 4-methyl-2,5-dimethoxyamphetamine (STP) (2,5-dimethoxy-4,α-dimethylbenzeneethanamine)
  • 3,4-Methylenedioxyamphetamine (MDA) (α-methyl-1,3-benzodioxole-5-ethanamine)
  • 2,5-dimethoxyamphetamine (2,5-dimethoxy-α-methylbenzene-ethanamine)
  • 4-methoxyamphetamine (4-methoxy-α-methylbenzeneethanamine)
  • 2,4,5-trimethoxyamphetamine (2,4,5-trimethoxy-α-methylbenzeneethanamine)
  • N-methyl-3,4-methylenedioxy- amphetamine (N,α-dimethyl-1,3-benzodioxole-5-ethanamine)
  • 4-ethoxy-2,5-dimethoxyamphetamine (4-ethoxy-2,5-dimethoxy-α-methylbenzeneethanamine)
  • 5-methoxy-3,4-methylenedioxy- amphetamine (7-methoxy-α-methyl-1,3-benzodioxole-5-ethanamine)
  • N,N-dimethyl-3,4-methylenedioxyamphetamine (N,N, α-trimethyl-1,3-benzodioxole-5-ethanamine)
  • N-ethyl-3,4-methylenedioxyamphetamine (N-ethyl-α-methyl-1,3-benzodioxole-5-ethanamine)
  • 4-ethyl-2,5-dimethoxyamphetamine (DOET) (4-ethyl-2,5-dimethoxy-α-methylbenzeneethanamine)
  • 4-bromo-2,5-dimethoxyamphetamine (4-bromo-2,5-dimethoxy-α-methylbenzeneethanamine)
  • 4-chloro-2,5-dimethoxyamphetamine (4-chloro-2,5-dimethoxy-α-methyl-benzeneethanamine)
  • 4-ethoxyamphetamine (4-ethoxy-α-methylbenzeneethanamine)
  • Benzphetamine (N-benzyl-N,α-dimethylbenzeneethanamine)
  • N-Propyl-3,4-methylenedioxy- amphetamine (α-methyl-N-propyl-1,3-benzodioxole-5-ethanamine)
  • N-(2-Hydroxyethyl)-α-meth-ylbenzeneethanamine
  • N-hydroxy-3,4-methylenedioxy- amphetamine (N-[α-methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine)
  • 3,4,5-trimethoxyamphetamine (3,4,5-trimethoxy-α-methylbenzeneethanamine)
  • Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any of its salts or derivatives
  • 4-hydroxybutanoic acid (GHB) and any of its salts
  • Tapentadol (3-[(1R,2R)-3-(dimethylamino)-1-ethyl-2-methylpropyl]-phenol), its salts, derivatives and isomers and salts of derivatives and isomers
  • AH-7921 (1-(3,4-dichlorobenzamidomethyl)cyclohexyldimethylamine), its salts, isomers and salts of isomers
  • MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including:
  • Diphenidine (DEP) (1-(1,2-diphenylethyl)piperidine)
  • Methoxphenidine (2-MeO-Diphenidine, MXP) (1-[1-(2-methoxyphenyl)-2-phenylethyl]piperidine)
  • Ephenidine (NEDPA, EPE) (N-ethyl-1,2-diphenylethylamine)
  • Isophenidine (NPDPA) (N-isopropyl-1,2-diphenylethylamine)

but not including:

  • Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine), its salts, derivatives and isomers and salts of derivatives and isomers
  • W-18 (-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]benzenesulfonamide), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues

Schedule 11

  • Synthetic cannabinoid receptor type 1 agonists, their salts, derivatives, isomers, and salts of derivatives and isomers — with the exception of any substance that is identical to any phytocannabinoid and with the exception of ((3S)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-3) and its salts—including those that fall within the following core chemical structure classes:
  • Any substance that has a 2-(cyclohexyl)phenol structure with substitution at the 1-position of the benzene ring by a hydroxy, ether or ester group and further substituted at the 5-position of the benzene ring, whether or not further substituted on the benzene ring to any extent, and substituted at the 3′-position of the cyclohexyl ring by an alkyl, carbonyl, hydroxyl, ether or ester, and whether or not further substituted on the cyclohexyl ring to any extent, including
    • Nabilone ((±)-trans-3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a-hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo[b,d]pyran-9-one)
    • Parahexyl (3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol)
    • 3-(1,2-dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol (DMHP)
    • 5-(1,1-dimethylheptyl)-2-(5-hydroxy-2-(3-hydroxypropyl)cyclohexyl)phenol (CP 55,940)
    • 5-(1,1-dimethylheptyl)-2-(3-hydroxycyclohexyl)phenol (CP 47,497)
  • Any substance that has a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
    • 1-pentyl-3-(1-naphthoyl)indole (JWH-018)
    • 1-butyl-3-(1-naphthoyl)indole (JWH-073)
    • 1-pentyl-3-(4-methyl-1-naphthoyl)indole (JWH-122)
    • 1-hexyl-3-(1-naphthoyl)indole (JWH-019)
    • 1-(4-pentenyl)-3-(1-naphthoyl)indole (JWH-022)
    • 1-butyl-3-(4-methoxy-1-naphthoyl)indole (JWH-080)
    • 1-pentyl-3-(4-methoxy-1-naphthoyl)indole (JWH-081)
    • 1-(2-morpholin-4-ylethyl)-3-(1-naphthoyl)indole (JWH-200)
    • 1-pentyl-3-(4-ethyl-1-naphthoyl)indole (JWH-210)
    • 1-pentyl-3-(2-methoxy-1-naphthoyl)indole (JWH-267)
    • 1-[(N-methylpiperidin-2-yl)methyl]-3-(1-naphthoyl)indole (AM-1220)
    • 1-(5-fluoropentyl)-3-(1-naphthoyl)indole (AM-2201)
    • 1-(5-fluoropentyl)-3-(4-methyl-1-naphthoyl)indole (MAM-2201)
    • 1-(5-fluoropentyl)-3-(4-ethyl-1-naphthoyl)indole (EAM-2201)
    • ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl)-1-naphthalenyl-methanone (WIN 55,212-2)
  • Any substance that has a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring, whether or not further substituted on the pyrrole ring to any extent and whether or not substituted on the naphthyl ring to any extent, including
    • 1-pentyl-5-(2-fluorophenyl)-3-(1-naphthoyl)pyrrole (JWH-307)
  • Any substance that has a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
    • 1-pentyl-3-(2-methoxyphenylacetyl)indole (JWH-250)
    • 1-pentyl-3-(2-methylphenylacetyl)indole (JWH-251)
    • 1-pentyl-3-(3-methoxyphenylacetyl)indole (JWH-302)
  • Any substance that has a 3-benzoylindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the phenyl ring to any extent, including
    • 1-(1-methylpiperidin-2-ylmethyl)-3-(2-iodobenzoyl)indole (AM-2233)
  • Any substance that has a 3-methanone(cyclopropyl)indole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the cyclopropyl ring to any extent, including
    • (1-pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (UR-144)
    • (1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (5F-UR-144)
    • (1-(2-(4-morpholinyl)ethyl)-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)-methanone (A-796,260)
  • Any substance that has a quinolin-8-yl 1H-indole-3-carboxylate structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted on the quinolin-8-yl ring to any extent, including
    • 1-pentyl-8-quinolinyl ester-1H-indole-3-carboxylic acid (PB-22)
    • 1-(5-fluoropentyl)-8-quinolinyl ester-1H-indole-3-carboxylic acid (5F-PB-22)
  • Any substance that has a 3-carboxamideindazole structure with substitution at the nitrogen atom of the indazole ring, whether or not further substituted on the indazole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
    • N-(adamantan-1-yl)-1-pentyl-1H-indazole-3-carboxamide (AKB48)
    • N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide (5F-AKB48)
    • N-(1-(aminocarbonyl)-2-methylpropyl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA)
    • N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA)
  • Any substance that has a 3-carboxamideindole structure with substitution at the nitrogen atom of the indole ring, whether or not further substituted on the indole ring to any extent and whether or not substituted at the carboxamide group to any extent, including
    • N-(adamantan-1-yl)-1-fluoropentylindole-3-carboxamide (STS-135)
    • N-(adamantan-1-yl)-1-pentylindole-3-carboxamide (APICA)

Schedule III

  • Adsa
  • Methylphenidate (α-phenyl-2-piperidineacetic acid methyl ester) and any salts, derivatives, isomers, and analogues and salts of derivatives, isomers, and analogues, including:
  • Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
  • Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)
  • Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)
  • 3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin-2-yl)acetate)
  • 4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin-2-yl)acetate)
  • 4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)
  • Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
  • Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
  • Methaqualone (2-methyl-3-(2-methylphenyl)-4(3H)-quinazolinone) and any salt thereof
  • Mecloqualone (2-methyl-3-(2-chlorophenyl)-4(3H)-quinazolinone) and any salt thereof 11
  • LSD (lysergic acid diethylamide) (N,N-diethyllysergamide) and any salt thereof
  • DET (N,N-Diethyltryptamine) (3-[(2-diethylamino) ethyl]indole) and any salt thereof
  • DMT (N,N-Dimethyltryptamine) (3-[(2-dimethylamino) ethyl]indole) and any salt thereof
  • N-Methyl-3-piperidyl benzilate (LBJ) (3-[(hydroxydiphenylacetyl)oxy]-1-methylpiperidine) and any salt thereof
  • Harmaline (4,9-dihydro-7-methoxy-1-methyl-3H-pyrido(3,4-b)indole) and any salt thereof
  • Harmalol (4,9-dihydro-1-methyl-3H-pyrido(3,4-b)indol-7-ol) and any salt thereof
  • Psilocin (3-[2-(dimethylamino)ethyl]-4-hydroxyindole) and any salt thereof
  • Psilocybin (3-[2-(dimethylamino)ethyl]-4-phosphoryloxyindole) and any salt thereof
  • PCE (N-(1-phenylcyclohexyl)ethylamine) and any salt thereof
  • TCP (1-[1-(2-Thienyl) cyclohexyl]piperidine) and any salt thereof
  • PCPr (1-Phenyl-N-propylcyclohexanamine) and any salt thereof
  • Rolicyclidine (1-(1-phenylcyclohexyl) pyrrolidine) and any salt thereof
  • Mescaline (3,4,5-trimethoxybenzeneethanamine) and any salt thereof, but not peyote (lophophora)
  • 4-Methylaminorex (4,5-dihydro-4-methyl-5-phenyl-2-oxazolamine) and any salt thereof
  • Cathinone ((-)-α-aminopropiophenone) and any salt thereof
  • Fenetylline (d,l-3,7-dihydro-1,3-dimethyl-7-(2-[(1-methyl-2-phenethyl)amino]ethyl)-1H-purine-2, 6-dione) and any salt thereof
  • Methcathinone (2-Methylamino-1-phenyl-1-propanone) and any salt thereof
  • Benzylcyclidine (1-[1-(Phenylmethyl)cyclohexyl]piperidine) and any salt thereof
  • 4-methyl-PCP (1-[1-(4-Methylphenyl)cyclohexyl]piperidine) and any salt thereof
[Repealed, SOR/2016-73, s. 1] [Repealed, 2012, c. 1, s. 46] [Repealed, 2012, c. 1, s. 46]
  • Aminorex (4,5-dihydro-5-phenyl-2-oxazolamine) and any salt thereof
  • Etryptamine (3-(2-aminobutyl)indole) and any salt thereof
  • Lefetamine ((-)-N,N-dimethyl-α-phenylbenzeneethanamine) and any salt thereof
  • Mesocarb (3-(α-methylphenethyl)-N-(phenylcarbamoyl)sydnone imine) and any salt thereof
  • Zipeprol (4-(2-methoxy-2-phenylethyl)-α-(methoxyphenylmethyl)-1-piperazineethanol) and any salt thereof
  • Amineptine (7-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) and any salt thereof
  • BZP (Benzylpiperazine) (1-benzylpiperazine) and its salts, isomers and salts of isomers
  • TFMPP (Trifluoromethylphenylpiperazine) (1-(3-trifluoromethylphenyl)piperazine) and its salts, isomers and salts of isomers
  • 2C-phenethylamines and their salts, derivatives, isomers and salts of derivatives and isomers that correspond to the following chemical description:
  • any substance that has a 1-amino-2-phenylethane structure substituted at the 2′ and 5′ or 2′ and 6′ positions of the benzene ring by an alkoxy or haloalkoxy group, or substituted at two adjacent carbon atoms of the benzene ring which results in the formation of a furan, dihydrofuran, pyran, dihydropyran or methylenedioxy group—whether or not further substituted on the benzene ring to any extent, whether or not substituted at the amino group by one or two, or a combination of, methyl, ethyl, propyl, isopropyl, hydroxyl, benzyl (or benzyl substituted to any extent) or benzylene (or benzylene substituted to any extent) groups and whether or not substituted at the 2-ethyl (beta carbon) position by a hydroxyl, oxo or alkoxy group—and its salts and derivatives and salts of derivatives, including:
  • 4-bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe)
  • 4-chloro-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25C-NBOMe)
  • 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)
  • 4-bromo-2,5-dimethoxybenzeneethanamine (2C-B)

Schedule IV

  • Barbiturates, their salts and derivatives including
  • Allobarbital (5,5-diallylbarbituric acid)
  • Alphenal (5-allyl-5-phenylbarbituric acid)
  • Amobarbital (5-ethyl-5-(3-methylbutyl)barbituric acid)
  • Aprobarbital (5-allyl-5-isopropylbarbituric acid)
  • Barbital (5,5-diethylbarbituric acid)
  • [Repealed, SOR/2017-13, s. 7]
  • Butabarbital (5-sec-butyl-5-ethylbarbituric acid)
  • Butalbital (5-allyl-5-isobutylbarbituric acid)
  • Butallylonal (5-(2-bromoallyl)-5-sec-butylbarbituric acid)
  • Butethal (5-butyl-5-ethylbarbituric acid)
  • Cyclobarbital (5-(1-cyclohexen-1-yl)-5-ethylbarbituric acid)
  • Cyclopal (5-allyl-5-(2-cyclopenten-1-yl)barbituric acid)
  • Heptabarbital (5-(1-cyclohepten-1-yl)-5-ethylbarbituric acid)
  • Hexethal (5-ethyl-5-hexylbarbituric acid)
  • Hexobarbital (5-(1-cyclohexen-1-yl)-1,5-dimethylbarbituric acid)
  • Mephobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)
  • Methabarbital (5,5-diethyl-1-methylbarbituric acid)
  • Methylphenobarbital (5-ethyl-1-methyl-5-phenylbarbituric acid)
  • Propallylonal (5-(2-bromoallyl)-5-isopropylbarbituric acid)
  • Pentobarbital (5-ethyl-5-(1-methylbutyl)barbituric acid)
  • Phenobarbital (5-ethyl-5-phenylbarbituric acid)
  • Probarbital (5-ethyl-5-isopropylbarbituric acid)
  • Phenylmethylbarbituric acid (5-methyl-5-phenylbarbituric acid)
  • Secobarbital (5-allyl-5-(1-methylbutyl)barbituric acid)
  • Sigmodal (5-(2-bromoallyl)-5-(1-methylbutyl) barbituric acid)
  • Talbutal (5-allyl-5-sec-butylbarbituric acid)
  • Vinbarbital (5-ethyl-5-(1-methyl-1-butenyl)barbituric acid)
  • Vinylbital (5-(1-methylbutyl)-5-vinylbarbituric acid)
  • but not including:
  • Barbituric acid (2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
  • 1,3-dimethylbarbituric acid (1,3-dimethyl-2,4,6(1H,3H,5H)-pyrimidinetrione) and its salts
  • Thiobarbiturates, their salts and derivatives including:
  • Thialbarbital (5-allyl-5-(2-cyclohexen-1-yl)-2-thiobarbituric acid)
  • Thiamylal (5-allyl-5-(1-methylbutyl)-2-thiobarbituric acid)
  • Thiobarbituric acid (2-thiobarbituric acid)
  • Thiopental (5-ethyl-5-(1-methylbutyl)-2-thiobarbituric acid)
  • Chlorphentermine (1-(p-chlorophenyl)-2-methyl-2-aminopropane) and any salt thereof
  • Diethylpropion (2-(diethylamino)propiophenone) and any salt thereof
  • Phendimetrazine (d-3,4-dimethyl-2-phenylmorpholine) and any salt thereof
  • Phenmetrazine (3-methyl-2-phenylmorpholine) and any salt thereof
  • Pipradrol (α,α-diphenyl-2-piperidinemethanol) and any salt thereof
  • Phentermine (α,α-dimethylbenzeneethanamine) and any salt thereof
  • Butorphanol (l-N-cyclobutylmethyl-3,14-dihydroxymorphinan) and any salt thereof
  • Nalbuphine (N-cyclobutylmethyl-4,5-epoxy-morphinan-3,6,14-triol) and any salt thereof
  • Glutethimide (2-ethyl-2-phenylglutarimide)
  • Clotiazepam (5-(o-chlorophenyl)-7-ethyl-1,3-dihydro-1-methyl-2H-thieno[2,3-e]-1,4-diazepin-2-one) and any salt thereof
  • Ethchlorvynol (ethyl-2-chlorovinyl ethynyl carbinol)
  • Ethinamate (1-ethynylcyclohexanol carbamate)
  • Mazindol (5-(p-chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol)
  • Meprobamate (2-methyl-2-propyl-1,3-propanediol dicarbamate)
  • Methyprylon (3,3-diethyl-5-methyl-2,4-piperidinedione)
  • Benzodiazepines, their salts and derivatives, including:
  • Alprazolam (8-chloro-1-methyl-6-phenyl-4H-s-triazolo[4,3-a][1,4] benzodiazepine)
  • Bromazepam (7-bromo-1,3-dihydro-5-(2-pyridyl)-2H-1, 4-benzodiazepin-2-one)
  • Brotizolam (2-bromo-4-(o-chlorophenyl)-9-methyl-6H-thieno[3,2-f]-s-triazolo[4,3-a][1,4]diazepine)
  • Camazepam (7-chloro-1,3-dihydro-3-(N,N- dimethylcarbamoyl)-1-methyl-5-phenyl-2H-1, 4-benzodiazepin-2-one)
  • Chlordiazepoxide (7-chloro-2-(methylamino)-5-phenyl-3H-1,4-benzodiazepine-4-oxide)
  • Clobazam (7-chloro-1-methyl-5-phenyl-1H-1,5-benzodiazepine-2,4(3H,5H)-dione)
  • Clonazepam (5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one)
  • Clorazepate (7-chloro-2,3-dihydro-2,2-dihydroxy-5-phenyl-1H-1,4-benzodiazepine-3-carboxylic acid)
  • Cloxazolam (10-chloro-11b-(o-chlorophenyl)-2,3, 7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin 6-(5H)-one)
  • Delorazepam (7-chloro-5-(o-chlorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
  • Diazepam (7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Estazolam (8-chloro-6-phenyl-4H-s-triazolo [4,3-a][1,4]benzodiazepine)
  • Ethyl Loflazepate (ethyl 7-chloro-5-(o-fluorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepine-3-carboxylate)
  • Fludiazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
  • [Repealed, SOR/98-173, s. 2]
  • Flurazepam (7-chloro-1-[2-(diethylamino) ethyl]-5-(o-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
  • Halazepam (7-chloro-1,3-dihydro-5-phenyl-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepin-2-one)
  • Haloxazolam (10-bromo-11b-(o-fluorophenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one)
  • Ketazolam (11-chloro-8,12b-dihydro-2,8-dimethyl-12b-phenyl-4H-[1,3]-oxazino-[3,2-d][1,4] benzodiazepine-4,7(6H)-dione)
  • Loprazolam (6-(o-chlorophenyl)-2,4-dihydro-2-[(4-methyl-1-piperazinyl)methylene]-8-nitro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-one)
  • Lorazepam (7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one)
  • Lormetazepam (7-chloro-5-(o-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one)
  • Medazepam (7-chloro-2,3-dihydro-1-methyl-5-phenyl-1H-1,4-benzodiazepine)
  • Midazolam (8-chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine)
  • Nimetazepam (1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Nitrazepam (1,3-dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Nordazepam (7-chloro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Oxazepam (7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Oxazolam (10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyloxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-one)
  • Pinazepam (7-chloro-1,3-dihydro-5-phenyl-1-(2-propynyl)-2H-1,4-benzodiazepin-2-one)
  • Prazepam (7-chloro-1-(cyclopropylmethyl)-1, 3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Quazepam (7-chloro-5-(o-fluorophenyl)-1,3-dihydro-1-(2,2,2-trifluoroethyl)-2H-1,4-benzodiazepine-2-thione)
  • Temazepam (7-chloro-1,3-dihydro-3-hydroxy-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one)
  • Tetrazepam (7-chloro-5-(cyclohexen-1-yl)-1,3-dihydro-1-methyl-2H-1,4-benzodiazepin-2-one)
  • Triazolam (8-chloro-6-(o-chlorophenyl)-1-methyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine)
  • but not including:
  • Clozapine (8-chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and any salt thereof
  • Flunitrazepam (5-(o-fluorophenyl)-1,3-dihydro-1-methyl-7-nitro-2H-1,4-benzodiazepin-2-one) and any salts or derivatives thereof
  • Olanzapine (2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine) and its salts
  • Clozapine N-oxide (8-chloro-11-(4-methyl-4-oxido-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) and its salts
  • Catha edulis Forsk., its preparations, derivatives, alkaloids and salts, including:
  • Cathine (d-threo-2-amino-1-hydroxy-1-phenylpropane)
  • Fencamfamin (d,l-N-ethyl-3-phenylbicyclo[2,2,1] heptan-2-amine) and any salt thereof
  • Fenproporex (d,l-3-[(α-methylphenethyl)amino]propionitrile) and any salt thereof
  • Mefenorex (d,l-N-(3-chloropropyl)-α-methylbenzeneethanamine) and any salt thereof
  • Anabolic steroids and their derivatives including:
  • Androisoxazole (17ß-hydroxy-17α-methylandrostano [3,2-c]isoxazole)
  • Androstanolone (17ß-hydroxy-5α-androstan-3-one)
  • Androstenediol (androst-5-ene-3ß,17ß-diol)
  • Bolandiol (estr-4-ene-3ß,17ß-diol)
  • Bolasterone (17ß-hydroxy-7α,17-dimethylandrost-4-en-3-one)
  • Bolazine (17ß-hydroxy-2α-methyl-5α-androstan-3-one azine)
  • Boldenone (17ß-hydroxyandrosta-1,4-dien-3-one)
  • Bolenol (19-nor-17α-pregn-5-en-17-ol)
  • Calusterone (17ß-hydroxy-7ß,17-dimethylandrost-4-en-3-one)
  • Clostebol (4-chloro-17ß-hydroxyandrost-4-en-3-one)
  • Drostanolone (17ß-hydroxy-2α-methyl-5α-androstan-3-one)
  • Enestebol (4, 17ß-dihydroxy-17-methylandrosta-1,4-dien-3-one)
  • Epitiostanol (2α, 3α-epithio-5α-androstan-17ß-ol)
  • Ethylestrenol (19-nor-17α-pregn-4-en-17-ol)
  • 4-Hydroxy-19-nor testosterone
  • Fluoxymesterone (9-fluoro-11ß,17ß-dihydroxy-17-methylandrost-4-en-3-one)
  • Formebolone (11α, 17ß-dihydroxy-17-methyl-3-oxoandrosta-1,4 di-en-2-carboxaldehyde)
  • Furazabol (17-methyl-5α-androstano[2,3-c] furazan-17ß-ol)
  • Mebolazine (17ß-hydroxy-2α,17-dimethyl-5α-androstan-3-one azine)
  • Mesabolone (17ß-[(1-methoxycyclohexyl)oxy]-5α-androst-1-en-3-one)
  • Mesterolone (17ß-hydroxy-1α-methyl-5α-androstan-3-one)
  • Metandienone (17ß-hydroxy-17-methylandrosta-1,4-dien-3-one)
  • Metenolone (17ß-hydroxy-1-methyl-5α-androst-1-en-3-one)
  • Methandriol (17α-methylandrost-5-ene-3ß,17ß-diol)
  • Methyltestosterone (17ß-hydroxy-17-methylandrost-4-en-3-one)
  • Metribolone (17ß-hydroxy-17-methylestra-4, 9,11-trien-3-one)
  • Mibolerone (17ß-hydroxy-7α,17-dimethylestr-4-en-3-one)
  • Nandrolone (17ß-hydroxyestr-4-en-3-one)
  • Norboletone (13-ethyl-17ß-hydroxy-18, 19-dinorpregn-4-en-3-one)
  • Norclostebol (4-chloro-17ß-hydroxyestr-4-en-3-one)
  • Norethandrolone (17α-ethyl-17ß-hydroxyestr-4-en-3-one)
  • Oxabolone (4,17ß-dihydroxyestr-4-en-3-one)
  • Oxandrolone (17ß-hydroxy-17-methyl-2-oxa-5α-androstan-3-one)
  • Oxymesterone (4,17ß-dihydroxy-17-methylandrost-4-en-3-one)
  • Oxymetholone (17ß-hydroxy-2-(hydroxymethylene)-17-methyl-5α-androstan-3-one)
  • Prasterone (3ß-hydroxyandrost-5-en-17-one)
  • Quinbolone (17ß-(1-cyclopenten-1-yloxy) androsta-1,4-dien-3-one)
  • Stanozolol (17ß-hydroxy-17-methyl-5α-androstano [3,2-c]pyrazole)
  • Stenbolone (17ß-hydroxy-2-methyl-5α-androst-1-en-3-one)
  • Testosterone (17ß-hydroxyandrost-4-en-3-one)
  • Tibolone ((7α,17α)-17-hydroxy-7-methyl-19-norpregn-5(10) en-20-yn-3-one)
  • Tiomesterone (1α,7α-bis(acetylthio)-17ß -hydroxy-17-methylandrost-4-en-3-one)
  • Trenbolone (17ß-hydroxyestra-4,9,11-trien-3-one)
  • Zeranol (3,4,5,6,7,8,9,10,11,12-decahydro-7,14,16-trihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1-one)
  • Zolpidem (N,N,6-trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide) and any salt thereof
  • Pemoline (2-amino-5-phenyl-oxazolin-4-one) and any salt thereof
  • Pyrovalerone (4′-methyl-2-(1-pyrrolidinyl)valerophenone) and any salt thereof
  • Salvia divinorum (S. divinorum), its preparations and derivatives, including:
  • Salvinorin A ((2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester)

Schedule V

(Sections 2, 5 to 7.1, 10, 55 and 60.1)

1996, c. 19, Sch. V; SOR/2002-361, s. 1; SOR/2003-32, s. 7; 2017, c. 7, s. 50.

Schedule VI (Precursors)

PART 1

Class A Precursors

  • Acetic anhydride
  • N-Acetylanthranilic acid (2-acetamidobenzoic acid) and its salts
  • Anthranilic acid (2-aminobenzoic acid) and its salts
  • Ephedrine (erythro-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing ephedrine or any of its salts
  • Ergometrine (9,10-didehydro-N-(2-hydroxy-1-methylethyl)-6-methylergoline-8-carboxamide) and its salts
  • Ergotamine (12′-hydroxy-2′-methyl-5′-(phenylmethyl)ergotaman-3′,6′,18-trione) and its salts
  • Isosafrole (5-(1-propenyl)-1,3-benzodioxole)
  • Lysergic acid (9,10-didehydro-6-methylergoline-8-carboxylic acid) and its salts
  • 3,4-Methylenedioxyphenyl-2-propanone (1-(1,3-benzodioxole)-2-propanone)
  • Norephedrine (Phenylpropanolamine) and its salts
  • 1-Phenyl-2-propanone
  • Phenylacetic acid and its salts
  • Piperidine and its salts
  • Piperonal (1,3-benzodioxole-5-carboxaldehyde)
  • Potassium permanganate
  • Pseudoephedrine (threo-2-(methylamino)-1-phenylpropan-1-ol), its salts and any plant containing pseudoephedrine or any of its salts
  • Safrole (5-(2-propenyl)-1,3-benzodioxole) and any essential oil containing more than 4% safrole
  • Gamma-butyrolactone (dihydro-2(3H)-furanone)
  • 1,4-butanediol
  • Red Phosphorus
  • White Phosphorus
  • Hypophosphorous acid, its salts and derivatives
  • Hydriodic acid
  • Alpha-phenylacetoacetonitrile and its salts, isomers and salts of isomers

PART 2

Class B Precursors[notes 2]

  • Acetone
  • Diethyl ether
  • Hydrochloric acid
  • Methyl ethyl ketone
  • Sulphuric acid
  • Toluene

PART 3

Preparations and Mixtures

Any preparation or mixture that contains a precursor set out in Part 1, except items 20 to 23 [Red Phosphorus; White Phosphorus; Hypophosphorous acid, its salts and derivatives; Hydriodic acid], or in Part 2.

Schedule VII

[Repealed, 2018, c. 16, s. 205]

Schedule VIII

[Repealed, 2018, c. 16, s. 205]